Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

45.33
-0.2800-0.61%
Pre-market: 45.740.4100+0.90%09:28 EDT
Volume:7.61M
Turnover:344.95M
Market Cap:200.50B
PE:11.32
High:45.61
Open:45.28
Low:44.95
Close:45.61
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:0.68
T/O Rate:0.24%
Dividend:1.72
Dividend Rate:3.80%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.16
PE(LYR):12.52

Loading ...

Jefferies Reaffirms Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
May 29

Novo Nordisk Receives Indian Approval for Wegovy in Adolescents

Deep News
·
May 29

CVS Health Reinstates Coverage for Eli Lilly's Zepbound and Adds New Oral Weight-Loss Drug to Formulary

Deep News
·
May 29

Novo Nordisk A/S Stock Rises Thursday, Outperforms Market

Dow Jones
·
May 29

Movement Alert|Novo Nordisk Rises 3.18% in Regular Trading, EASL Conference MASH Data and Acquisition Rumors Boost Sentiment

Market Focus
·
May 28

Deutsche Bank Sticks to Its Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
May 28

Novo Nordisk Advances Oral Wegovy Lead As Investor Focus Shifts To Uptake

Simply Wall St.
·
May 28

France to reimburse weight-loss drugs from mid-June, health minister says

Reuters
·
May 28

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 1.46%

TIPRANKS
·
May 28

Novo Nordisk to showcase new data from its cardiometabolic portfolio at ADA

TIPRANKS
·
May 27

Sector Update: Healthcare

MT Newswires Live
·
May 27

Novo Nordisk A/S Stock Falls Tuesday, Underperforms Market

Dow Jones
·
May 27

European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

MT Newswires Live
·
May 26

Market Chatter: Generic Copy of Novo Nordisk's Ozempic Shot Approved in Brazil

MT Newswires Live
·
May 26

Generic Copy of Novo Nordisk's Ozempic Shot Approved by Brazil, Bloomberg Reports

MT Newswires Live
·
May 26

Does Medicine's New Obsession Really Work? -- Barrons.com

Dow Jones
·
May 26

Oral Wegovy And Cancer Signals Reframe Novo Nordisk GLP 1 Opportunity

Simply Wall St.
·
May 26

Kepler Capital Keeps Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
May 24

Does Medicine's New Obsession Really Work? -- Barron's

Dow Jones
·
May 23

Novo Nordisk's High-Dose Wegovy Single-Dose Pen Receives Positive EU CHMP Opinion

Deep News
·
May 23